Dulaglutide (Trulicity) studies: 418 papers with results
Page 4 of 9
- Comparative cardiovascular and renal outcomes of Liraglutide versus Dulaglutide in Asian type 2 diabetes patients.
Dai JW · Scientific reports · 2024
Observational study · 4 results
- Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications.
Fralick M · Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
Observational study · 3 results
- Comparative Effectiveness and Safety of Once-Weekly Injectable Semaglutide Versus Dulaglutide in Individuals with Type 2 Diabetes Managed in UK Primary Care: A Population-Based Cohort Study.
Ulrich FS · The Lancet regional health. Europe · 2026
Observational study · 14 results
- Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real-world setting: A prospective, observational post-marketing study.
Guo L · Diabetes, obesity & metabolism · 2023
Observational study · 11 results
- Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus: A Korean Real-World Post-Marketing Study.
Han J · Diabetes & metabolism journal · 2024
Observational study · 12 results
- The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes.
Giorgino F · Diabetes, obesity & metabolism · 2023
Observational study · 10 results
- ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide.
Bossi AC · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020
Observational study · 7 results
- Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses.
Pratley RE · BMJ open · 2020
Observational study · 11 results
- Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study.
Berra C · Pharmacological research · 2024
Observational study · 3 results
- Renoprotective effects of dulaglutide, a GLP-1 agonist, involving regulation of epithelial-mesenchymal transition in patients with type 2 diabetes and diabetic kidney disease.
Jiang D · International journal of clinical pharmacology and therapeutics · 2025
Observational study · 6 results
- One-year Efficacy and Safety of Dulaglutide in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Study of Asian Patients.
Kim MJ · Clinical therapeutics · 2024
Observational study · 4 results
- Real-world weight loss with injectable semaglutide vs dulaglutide for diabetes.
Spitery A · The American journal of managed care · 2026
Observational study · 14 results
- Real-World Efficacy and Safety of Dulaglutide in Korean Patients with Type 2 Diabetes Mellitus: A Retrospective Study in a Tertiary Referral Center.
Yoon JH · Chonnam medical journal · 2021
Observational study · 8 results
- The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia.
Albahli OM · Cureus · 2024
Observational study · 7 results
- Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin.
Uchinuma H · BMC endocrine disorders · 2020
Observational study · 6 results
- Real-world Impact of 3 and 4.5 mg Doses of Dulaglutide on Weight and Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus.
Duong A · The Annals of pharmacotherapy · 2024
Observational study · 6 results
- Efficacy and safety of tirzepatide in subjects with type 2 diabetes and chronic kidney disease: a prospective, two-arm observational study.
Oe Y · Therapeutic advances in endocrinology and metabolism · 2025
Observational study · 8 results
- Sodium-Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia : A Population-Based Cohort Study.
Hong B · Annals of internal medicine · 2024
Observational study · 2 results
- Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase.
Seijas-Amigo J · Primary care diabetes · 2023
Observational study · 15 results
- Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis.
Zimner Rapuch S · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
Observational study · 6 results
- Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.
Saeed A · Annals of internal medicine · 2025
Observational study · 8 results
- Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study.
Taipale H · The lancet. Psychiatry · 2026
Observational study · 10 results
- Comparison of Specific Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes Among Patients With Type 2 Diabetes.
Neumiller JJ · American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
Observational study · 8 results
- Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.
Taipale H · Acta psychiatrica Scandinavica · 2026
Observational study · 7 results
- Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes.
Mirabelli M · Journal of clinical medicine · 2021
Observational study · 10 results
- Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
Mirabelli M · Journal of the Endocrine Society · 2021
Observational study · 10 results
- Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND.
Konig M · Cardiovascular diabetology · 2021
Observational study · 8 results
- Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide.
Barkmeier AJ · Ophthalmology. Retina · 2026
Observational study · 18 results
- Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial.
Sklepinski SM · Diabetes research and clinical practice · 2025
Observational study · 14 results
- Greater Adherence and Persistence with Injectable Dulaglutide Compared with Injectable Semaglutide at 1-Year Follow-up: Data from US Clinical Practice.
Mody R · Clinical therapeutics · 2022
Observational study · 9 results
- Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach.
Henney AE · Diabetes, obesity & metabolism · 2026
Observational study · 6 results
- Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes.
Derington CG · JAMA network open · 2025
Observational study · 37 results
- Dulaglutide and neurodegeneration biomarkers: REWIND post hoc analysis.
Wilson JM · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
Observational study · 3 results
- Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide.
Milicevic Z · Diabetes, obesity & metabolism · 2016
Observational study · 7 results
- Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study.
Hoog M · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023
Observational study · 6 results
- Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real-world clinical practice: 36 month post-marketing observational study.
Chin R · Journal of diabetes investigation · 2023
Observational study · 14 results
- Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study.
Hoog M · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
Observational study · 9 results
- Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study.
Mody R · BMJ open diabetes research & care · 2019
Observational study · 7 results
- Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis.
Patel H · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2019
Observational study · 9 results
- Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.
Gerstein HC · Diabetes care · 2023
Observational study · 6 results
- Association of Dulaglutide Initiation Timing With Treatment Patterns and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus in the United States.
Hoog M · Clinical therapeutics · 2022
Observational study · 9 results
- Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients.
Morieri ML · The Journal of clinical endocrinology and metabolism · 2020
Observational study · 9 results
- Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials.
Guo L · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020
Observational study · 11 results
- Efficacy and Safety of Injectable Dulaglutide 1.5 mg Among Type 2 Diabetes Patients in Clinics at King Saud Medical City, Riyadh, Saudi Arabia.
Albargawi MS · Journal of epidemiology and global health · 2024
Observational study · 6 results
- Efficacy and Safety of Dulaglutide for Weight Reduction Among Diabetic Patients in Saudi Arabia: A Retrospective Cohort Study.
Alonazi GK · Cureus · 2025
Observational study · 5 results
- Real-world evaluation of the efficacy and safety of switching from weekly dulaglutide to weekly semaglutide: The SEMA-SWITCH study.
Pardo Lozano F · Endocrinologia, diabetes y nutricion · 2025
Observational study · 11 results
- Comparative effectiveness of semaglutide and dulaglutide combined with hypocaloric diet in newly diagnosed type 2 diabetes: a retrospective real-world study.
Cetiner S · BMC endocrine disorders · 2026
Observational study · 15 results
- Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study.
Lee J · Diabetes/metabolism research and reviews · 2021
Observational study · 4 results
- The effect of dulaglutide on glycated hemoglobin is associated with PNPLA3 Ι148Μ gene polymorphism in patients with type 2 diabetes mellitus.
Gavriilidis S · Endocrine · 2025
Observational study · 9 results
- Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study.
Terui S · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
Observational study · 12 results